• <em>STX16</em> exon 5-7 deletion in a patient with pseudohypoparathyroidism type 1B
• A case of treatment-resistant advanced gastric cancer with FGFR2 gene alteration successfully treated with pemigatinib
• A Phase 1 Study of KIN-3248, an irreversible small molecule pan-FGFR inhibitor, in Patients with Advanced FGFR 2/3 Driven Solid Tumors
• A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors
• A Sole Case of the FGF23 Gene Mutation c.202A&gt;G (p.Thr68Ala) Associated with Multiple Severe Vascular Aneurysms and a Hyperphosphatemic Variant of Tumoral Calcinosis-A Case Report
• A systematic review of online resources for the dietary management of hyperphosphatemia in people with chronic kidney disease
• An Open-Label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism
• An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202
• Assessment of the Correlation Between Serum Phosphate Level and Muscle Strength as Measured by Handgrip Strength in Patients Treated With Hemodialysis
• Association between CKD-MBD biomarkers and symptom burden in older patients with advanced CKD: Results from the EQUAL study
• Association Between the Serum Phosphate Levels and Hospital Mortality as Well as 90-Day Mortality Among Critically Ill Patients with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study
• Association of Circulating Endothelial Nitric Oxide Synthase Levels with Phosphataemia in Patients on Haemodialysis
• Augmentative effects of leukemia inhibitory factor reveal a critical role for TYK2 signaling in vascular calcification
• Beyond the Norm: Unusual Coexistence of Wilson's Disease and Hypoparathyroidism
• Characteristics, Risk Factors, and Outcomes in Acute Kidney Injury Patients: A Retrospective Cross-Sectional Study, Palestine
• Chronic Kidney Disease-associated Lung Injury Is Mediated by Phosphate-induced MAPK/AKT Signaling
• Clinical Characteristics and Outcomes of Hyperphosphatemia in patients with CKD Stages 1 to 2
• Comparative Analysis of Vascular Calcification Risk Factors in Pre-Hemodialysis and Prevalent Hemodialysis Adult Patients: Insights into Calcification Biomarker Associations and Implications for Intervention Strategies in Chronic Kidney Disease
• Crosstalk between kidney and bone: insights from CKD-MBD
• Current therapeutic approach of chronic kidney disease-mineral and bone disorder
• Dialysis-Reversible Complete Heart Block Without Severe Metabolic Derangements
• Dietary Phosphate Educational Materials for Pediatric Chronic Kidney Disease: Are Confused Messages Reducing Their Impact?
• Ectonucleotidase inhibitors: targeting signaling pathways for therapeutic advancement-an in-depth review
• Effect and safety of Burosumab in the treatment of 4 children with X-linked hypophosphatemia
• Effect of aspirin on cardiovascular events in patients undergoing hemodialysis with hyperphosphatemia: A post hoc analysis of the LANDMARK trial
• Effectiveness of tenapanor for treating hyperphosphatemia in patients receiving dialysis: a plain language summary of the OPTIMIZE study
• Effects of the novel sodium-dependent phosphate cotransporter 2b inhibitor DZ1462 on hyperphosphatemia in chronic kidney disease
• Efficacy, tolerability, and safety of the oral phosphate binder VS-505 (AP301)
• Endothelium-related biomarkers, hyperphosphatemia and mortality in hemodialysis patients: a moderation analysis
• Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
• Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial
• Exploration of low-phosphate diet management of patients receiving renal dialysis: An interpretive description
• Exploring the association between serum phosphate levels and mortality in patients hospitalized with infectious diseases: a nationwide study
• Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis
• FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
• First reported magnesium pyrophosphate kidney stone prompts diagnosis of hypophosphatasia
• Focal Seizures in a Patient With Chronic Basal Ganglia Calcifications Secondary to Idiopathic Primary Hypoparathyroidism
• Futibatinib: A Review in Locally Advanced and Metastatic Cholangiocarcinoma
• Hand Infections in End-Stage Renal Disease-Consider Tumoral Calcinosis
• Human milk derived fortifiers are associated with glucose, phosphorus, and calcium derangements
• Hyperphosphatemia and Zinc Deficiency in Chronic Kidney Disease: Unpacking Their Interconnected Roles and Nutritional Implications
• Hyperphosphatemia in Chronic Kidney Disease: The Search for New Treatment Paradigms and the Role of Tenapanor
• In vivo Mapping of the Mouse Galnt3-specific O-Glycoproteome
• Incidence of Electrolyte Imbalances Following Traumatic Rhabdomyolysis: A Systematic Review and Meta-Analysis
• Incidence of Post-Thyroidectomy Hypoparathyroidism and Associated Preoperative and Intraoperative Risk Factors
• Inorganic Phosphate-Induced Extracellular Vesicles from Vascular Smooth Muscle Cells Contain Elevated Levels of Hyaluronic Acid, Which Enhance Their Interaction with Very Small Superparamagnetic Iron Oxide Particles
• Lanthanum deposition of the gastric mucosa in a dialysis patient
• Lanthanum hydroxide protects kidney through gut microbiota in a rat model of chronic kidney disease
• Longitudinal Assessment of Health-Related Quality of Life in Three Different Hyperphosphatemia Management Groups of Stage III and IV Chronic Kidney Disease Patients
• Management of serum phosphorus over a 1-year follow-up in patients on peritoneal dialysis prescribed sucroferric oxyhydroxide as part of routine care: a retrospective analysis
• Mediterranean Diet for Cardiovascular Risk Reduction in Chronic Kidney Disease
• Nephrology: What You May Have Missed in 2023
• Normalizing serum phosphate based on association, not causation? Lessons in dialysis should have taught us not to fix what we can't prove is broken
• Novel genetic mutation associated with hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome treated with denosumab: a case report
• Nutritional management of hyperlipaemia in a jenny: a brief report
• Pediatric Hypophosphatasia: Avoid Diagnosis Missteps!
• Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial
• Peritoneal Phosphate Clearance: Determinants and Association With Mortality
• Persistent uncertainties in optimal treatment approaches of secondary hyperparathyroidism and hyperphosphatemia in patients with chronic kidney disease
• Phosphate-sensing mechanisms and functions of phosphate as a first messenger
• Phosphorus Content of Several Plant-Based Yogurts
• Pilot-scale co-precipitation synthesis of a novel active ingredient made of ultrasmall iron (oxyhydr)oxide nanoparticles for the treatment of hyperphosphatemia
• Plant-based diets in patients with chronic kidney disease
• Preclinical development of EXT608, an investigational parathyroid hormone derivative with extended half-life for the treatment of hypoparathyroidism
• Prospective multicenter study to describe the prevalence, outcomes, and management of phosphate disorders in intensive care patients: Study protocol for part B of the international GUTPHOS study
• Pseudohypoparathyroidism type 1B with involuntary movements: a case report and literature review
• Pseudohypoparathyroidism Type IB with Subclinical Hypothyroidism: a Pedigree Investigation and Literature Review
• Relationship between serum phosphorus and mortality in non-dialysis chronic kidney disease patients: evidence from NHANES 2001-2018
• Respiratory dysfunction in old mice could be related to inflammation and lung fibrosis induced by hyperphosphatemia
• Results of the EPISODE trial plead for reasonable practice-based serum phosphate lowering in patients on dialysis
• Retrospective analysis of predictive factors for AVF dysfunction in patients undergoing MHD
• Role of sphingolipid metabolism signaling in a novel mouse model of renal osteodystrophy based on transcriptomic approach
• Seeing the Whole Picture: Evaluating the Contribution of Whole Grains to Phosphorus Exposure in People With Kidney Failure Undergoing Dialysis Treatment
• Semaglutide and Patients Receiving Hemodialysis: Case Reports of Unexpected Benefits for Hyperphosphatemia and Hyperkalemia
• Serum electrolyte concentrations and risk of atrial fibrillation: an observational and mendelian randomization study
• Serum phosphate levels and the development of sepsis associated acute kidney injury: evidence from two independent databases
• Serum phosphate levels at diagnosis predict long-term risk for hypopituitarism in patients with acromegaly
• Sevelamer reverses liver fibrosis by deactivation of hepatic stellate cells
• Sevelamer-Induced Ischemic Enteritis
• Sex differences in chronic kidney disease-related complications and mortality across levels of glomerular filtration rate
• Short-term therapy with R568 ameliorated secondary hyperparathyroidism but does not prevent aortic valve calcification in uremic rats
• Skeletal Muscle Injury in Chronic Kidney Disease-From Histologic Changes to Molecular Mechanisms and to Novel Therapies
• Spatial Atlas for Mapping Vascular Microcalcification Using 18F-NaF PET/CT: Application in Hyperphosphatemic Familial Tumoral Calcinosis
• Spurious Hyperphosphatemia in a Patient with Chronic Kidney Disease - a Rare Case of Alteplase Contamination
• Spurious Hyperphosphatemia in Two Children With End-Stage Renal Disease: A Case Report
• Tenapanor (Xphozah) for hyperphosphatemia in chronic kidney disease
• Tenapanor improves long-term control of high phosphate concentrations in the blood in patients receiving maintenance dialysis: a plain language summary of the NORMALIZE study
• Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients with Kidney Failure
• The association between serum phosphate and length of hospital stay and all-cause mortality in adult patients: a cross-sectional study
• The Diagnosis of Albright's Osteodystrophy in a Case With Respiratory Failure
• The Effect of Niacinamide Supplementation on Phosphate Concentrations in Dutch Dialysis Patients: a randomised, crossover trial
• The Efficacy and Safety of High-Dose Cholecalciferol Therapy in Hemodialysis Patients
• The Hidden Link Between Chronic Kidney Disease and Lung Injury
• The impact of accessibility to non-calcium-based phosphate binders and calcimimetics on mineral outcomes in patients receiving maintenance hemodialysis: A 10-year retrospective analysis of real-world data
• The Intricacies of Renal Phosphate Reabsorption-An Overview
• The Relationship Between Fracture and Mortality in a Chinese Maintenance Hemodialysis Patients Cohort
• The role of fibroblast growth factor 23 in regulation of phosphate balance
• Three Siblings With a Rare Familial Hyperphosphatemia Syndrome: A Case Series
• Tumour lysis syndrome
• Vara Deformity and Subluxed Humeral Heads: An Unusual Sign in Pseudohypoparathyroidism